Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
8.63
+0.16 (1.89%)
At close: Dec 20, 2024, 4:00 PM
8.50
-0.13 (-1.50%)
After-hours: Dec 20, 2024, 7:55 PM EST

Anavex Life Sciences Market Cap

Anavex Life Sciences has a market cap or net worth of $731.79 million as of December 20, 2024. Its market cap has increased by 9.65% in one year.

Market Cap
731.79M
Enterprise Value
593.03M
1-Year Change
9.65%
Ranking
Category
Stock Price
$8.63

Market Cap Chart

Since January 25, 2007, Anavex Life Sciences's market cap has increased from $59.50M to $731.79M, an increase of 1,129.89%. That is a compound annual growth rate of 15.04%.

History

DateMarket Cap% Change
Dec 20, 2024731.80M-4.24%
Dec 29, 2023764.20M5.86%
Dec 30, 2022721.90M-45.24%
Dec 31, 20211.32B264.55%
Dec 31, 2020361.60M148.69%
Dec 31, 2019145.40M100.00%
Dec 31, 201872.70M-48.95%
Dec 29, 2017142.40M-9.24%
Dec 30, 2016156.90M-18.58%
Dec 31, 2015192.70M1,752.88%
Dec 31, 201410.40M11.83%
Dec 31, 20139.30M-61.09%
Dec 31, 201223.90M-28.01%
Dec 30, 201133.20M-63.79%
Dec 31, 201091.70M102.88%
Dec 31, 200945.20M-12.23%
Dec 31, 200851.50M-48.91%
Dec 31, 2007100.80M69.41%
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Tyra Biosciences 766.64M
Castle Biosciences 758.72M
uniQure 754.06M
Standard BioTools 738.93M
Cronos Group 725.92M
Avanos Medical 713.88M
Oculis Holding AG 713.48M
Relay Therapeutics 713.05M
Market Cap Rankings